December 2023 - Gastroenterology Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
CPT codes and LOINC update: January 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of January.
October 2023 - Pulmonary Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.
April 2022 - Breast Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
People Archives - Page 29 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Immunobullous Diseases: Paraneoplastic Pemphigus (PNP) - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss a rare and potentially fatal mucocutaneous blistering disease that is often associated with an underlying malignancy, called paraneoplastic pemphigus. She will also discuss the...
Cardiovascular Events in Patients With or Without Coronary Artery Disease
A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as...
A Test in Focus Archives - Page 4 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Urinary ammonium testing - Insights
John Lieske, M.D., discusses Mayo Clinic Laboratories' urinary ammonium testing. A test that takes the guesswork out of determining acid base disorders by giving nephrologists a true understanding of a patient’s true urinary ammonium level.
Enhanced detection of genetic mutation to optimize leukemia treatment - Insights
Rong He, M.D., describes how Mayo Clinic Laboratories’ NPM1Q assay detects all known forms of a genetic mutation found in about 30% of people with acute myeloid leukemia, or AML. Identifying the NPM1 mutation is critical for clinical...